We are live on ! Find out more
CRMD icon

CorMedix
CRMD

54 hedge funds and large institutions have $20.5M invested in CorMedix in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 11

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

27% more capital invested

Capital invested by funds: $16.2M → $20.5M (+$4.36M)

4% more funds holding

Funds holding: 52 → 54 (+2)

0.21% less ownership

Funds ownership: 4.51% → 4.29% (-0.21%)

98% less call options, than puts

Call options by funds: $21K | Put options by funds: $1.24M

Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
18
Reduced
11
Closed
5
Calls
$21K
Puts
$1.24M
Net Calls
-$1.22M
Net Calls Change
+$17K

Top Buyers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
+$237K
2
BCM
Bridgeway Capital Management
Texas
+$126K
3
Goldman Sachs
Goldman Sachs
New York
+$88.6K
4
PAG
Private Advisor Group
New Jersey
+$79.2K
5
GLRA
Gerald L. Ray & Associates
Texas
+$69.9K

Top Sellers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
-$488K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$296K
3
ST
Spot Trading
Illinois
-$226K
4
UBS Group
UBS Group
Switzerland
-$180K
5
Millennium Management
Millennium Management
New York
-$122K

CRMD Hedge Fund Activity: Q1 2016 in Review

54 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2016, worth a combined $20.5M — up 27% from $16.2M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CRMD positions and 5 closed out — a net gain of 2 holders — while 18 added to existing stakes and 11 trimmed.

The largest buyer was Group One Trading, adding an estimated $237K. The largest seller was AQR Capital Management, cutting an estimated $488K.

  • 54 institutional investors held CorMedix (CRMD) as of Q1 2016, up from 52 in Q4 2015.
  • Funds reported $20.5M of CorMedix stock for Q1 2016, up 27% quarter-over-quarter.
  • 7 funds opened new CorMedix positions in Q1 2016 and 5 closed out, a net change of +2 holders.
  • The largest CorMedix buyer in Q1 2016 was Group One Trading, an estimated $237K added.
  • The largest CorMedix seller in Q1 2016 was AQR Capital Management, an estimated $488K sold.

Based on aggregated 13F filings for Q1 2016.